Skip to main content
Elsevier - PMC COVID-19 Collection logoLink to Elsevier - PMC COVID-19 Collection
letter
. 2020 Dec 18;397(10269):93–94. doi: 10.1016/S0140-6736(20)32651-9

Infectivity of asymptomatic versus symptomatic COVID-19

Andrew A Sayampanathan a, Cheryl S Heng a, Phua Hwee Pin a, Junxiong Pang a,b, Teoh Yee Leong a,b,c, Vernon J Lee a,b
PMCID: PMC7836843  PMID: 33347812

Asymptomatic cases of COVID-19 are a potential source of substantial spread within the community setting.1 However, little information is available about the infectivity and epidemiological significance of people with asymptomatic COVID-19.2

Singapore's testing strategy for severe acute respiratory syndrome coronavirus 2 is designed to detect infection in both symptomatic and asymptomatic people. Various methods are used. Workers in specific industries, such as construction, marine, and process industries, are routinely tested once per week or every two weeks, and all close contacts of those who test positive for COVID-19 are tested as well. All COVID-19 case detection, regardless of symptom status, triggers public health actions, including contact tracing and the quarantining of close contacts. A close contact generally refers to a person who was within 2 m of the index case for at least 30 min (or for shorter durations in high-risk settings).3 All quarantined people are tested by PCR at the end of their quarantine period, and are only released from quarantine when they test negative for COVID-19. Serology tests are also done in most people who are infected, to determine the possible duration of their COVID-19 infection, and to assist with epidemiological investigations and containment efforts.3 As COVID-19 viral load is typically higher before seroconversion than after, seronegative cases are thought to be more infectious than seropositive cases.4, 5

To identify the relative infectivity of people with COVID-19 on the basis of their symptom and serology status, we studied all people who completed their quarantine between Aug 1 and Oct 11, 2020, as a result of being close community contacts of people who were infected and who had also undergone serology tests as part of their COVID-19 status assessment. Close contacts who lived in migrant worker dormitories were excluded from this analysis because their living environments were contextually different from community close contacts and because there were separate challenges in identifying cases and their close contacts within the dormitories. Negative binomial regression was done using Python version 3.7.1 (Python Software Foundation, Wilmington, DE, USA) to calculate the incidence rate ratios of a quarantined person from the community testing positive for COVID-19, adjusting for the symptom and serology status of the index case; two-tailed statistical significance was set at 0·05.

628 people with COVID-19 were included in this analysis (appendix). 3790 people were close contacts of an index case and were quarantined. On average, 6·0 people from the community were quarantined per index case. Overall, 89 (2%) of 3790 close community contacts developed COVID-19 while in quarantine. Of these, 50 (56%) of 89 contacts were quarantined because of an asymptomatic index case, whereas 39 (44%) contacts were quarantined because of a symptomatic case.43 (48%) contacts were quarantined because of a seronegative index case, whereas 46 (52%) were quarantined because of a seropositive index case.

Negative binomial regression revealed that when adjusted for age, gender, and serology of index case, the incidence of COVID-19 among close contacts of a symptomatic index case was 3·85 times higher than for close contacts of an asymptomatic index case (95% CI2·06–7·19; p<0·0001; appendix).

Our findings suggest that people with asymptomatic COVID-19 are infectious but might be less infectious than symptomatic cases. We also identified that the proportion of close contacts who became infected did not depend on the serology status of the index case. One reason for this observation could be that close contacts tend to live or work with the index case and are exposed because of their regular contact with a person who was infectious before turning seropositive.

The main limitation of this analysis is that cycle threshold values and viable shedding data were not available for all individuals included. Future studies should explore the relationship between viral loads, viable shedding, and transmission. Nevertheless, these findings suggest that where resources permit, contact tracing should proactively seek people with asymptomatic COVID-19 because they can transmit disease and will need to be contained if a national policy objective is to minimise cases and transmission. However, if resources are limited, then focusing contact tracing around symptomatic people who are easy to identify (by way of them seeking health care) might be more resource-effective in reducing transmission at the population level.

graphic file with name fx1_lrg.jpg

© 2021 Catherine Lai/Getty Images

Acknowledgments

We declare no competing interests.

Supplementary Material

Supplementary appendix
mmc1.pdf (167.1KB, pdf)

References

  • 1.Kronbichler A, Kresse D, Yoon S, Lee KH, Effenberger M, Shin JI. Asymptomatic patients as a source of COVID-19 infections: a systematic review and meta-analysis. Int J of Inf Dis. 2020;98:180–186. doi: 10.1016/j.ijid.2020.06.052. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Gao M, Yang L, Chen X, et al. A study on infectivity of asymptomatic SARS-CoV-2 carriers. Respiratory Medicine. 2020;169:1–5. doi: 10.1016/j.rmed.2020.106026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Yong SEF, Anderson DE, Wei WE, et al. Connecting clusters of COVID-19: an epidemiological and serological investigation. Lancet. 2020;20:809–815. doi: 10.1016/S1473-3099(20)30273-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Peeling RW, Weddenburn CJ, Garcia PJ, et al. Serology testing in the COVID-19 pandemic response. Lancet. 2020;20:e245–e249. doi: 10.1016/S1473-3099(20)30517-X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5.Zhao J, Yuan Q, Wang H, et al. Antibody responses to SARS-CoV-2 in patients of novel coronavirus disease 2019. Clin Infec Dis71: 2027–34. [DOI] [PMC free article] [PubMed]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplementary appendix
mmc1.pdf (167.1KB, pdf)

Articles from Lancet (London, England) are provided here courtesy of Elsevier

RESOURCES